Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment: A Systematic Review

Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment: A Systematic Review

<b>Background:</b> Polycystic ovary syndrome (PCOS) is a chronic disorder and is one of the most common endocrine disorders in women of a reproductive age. The prevalence of PCOS is growing globally; 52% of women in Southeast Asia alone suffer from this disorder. This disorder is caused...

Full description

Bibliographic Details
Main Authors: Gunawan Dwi Prayitno, Keri Lestari, Cynthia Retna Sartika, Tono Djuwantono, Andi Widjaya, R. Muharam, Yudi Mulyana Hidayat, Dewi Wulandari, Rima Haifa, Nabilla Farah Naura, Kristin Talia Marbun, Annisah Zahrah
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Medicines
Subjects:
polycystic ovary syndrome
inflammation
insulin resistance
stem cells
conditioned medium
Online Access:https://www.mdpi.com/2305-6320/10/1/3

Internet

https://www.mdpi.com/2305-6320/10/1/3

Similar Items